|
Hits: 1074
Every family wants to determine what treatment will be most
effective for their child. This question needs to be answered by each
family in consultation with their health care professional. To help
families make this important decision, the National Institute of Mental
Health (NIMH) has funded many studies of treatments for ADHD and has
conducted the most intensive study ever undertaken for evaluating the
treatment of this disorder. This study is known as the Multimodal
Treatment Study of Children with Attention Deficit Hyperactivity
Disorder (MTA).12
The NIMH is now conducting a clinical trial for younger children ages 3
to 5.5 years (Treatment of ADHD in Preschool-Age Children).
The Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder.
The MTA study included 579 (95-98 at each of 6 treatment sites)
elementary school boys and girls with ADHD, who were randomly assigned
to one of four treatment programs: (1) medication management alone; (2)
behavioral treatment alone; (3) a combination of both; or (4) routine
community care. In each of the study sites, three groups were treated
for the first 14 months in a specified protocol and the fourth group
was referred for community treatment of the parents' choosing. All of
the children were reassessed regularly throughout the study period. An
essential part of the program was the cooperation of the schools,
including principals and teachers. Both teachers and parents rated the
children on hyperactivity, impulsivity, and inattention, and symptoms
of anxiety and depression, as well as social skills.
The children in two groups (medication management alone and the
combination treatment) were seen monthly for one-half hour at each
medication visit. During the treatment visits, the prescribing
physician spoke with the parent, met with the child, and sought to
determine any concerns that the family might have regarding the
medication or the child's ADHD-related difficulties. The physicians, in
addition, sought input from the teachers on a monthly basis. The
physicians in the medication-only group did not provide behavioral
therapy but did advise the parents when necessary concerning any
problems the child might have.
In the behavior treatment-only group, families met up to 35 times
with a behavior therapist, mostly in group sessions. These therapists
also made repeated visits to schools to consult with children's
teachers and to supervise a special aide assigned to each child in the
group. In addition, children attended a special 8-week summer treatment
program where they worked on academic, social, and sports skills, and
where intensive behavioral therapy was delivered to assist children in
improving their behavior.
Children in the combined therapy group received both treatments,
that is, all the same assistance that the medication-only received, as
well as all of the behavior therapy treatments.
In routine community care, the children saw the community-treatment
doctor of their parents' choice one to two times per year for short
periods of time. Also, the community-treatment doctor did not have any
interaction with the teachers.
The results of the study indicated that long-term combination
treatments and the medication-management alone were superior to
intensive behavioral treatment and routine community treatment. And in
some areas—anxiety, academic performance, oppositionality, parent-child
relations, and social skills—the combined treatment was usually
superior. Another advantage of combined treatment was that children
could be successfully treated with lower doses of medicine, compared
with the medication-only group.
Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS).
Because many children in the preschool years are diagnosed with ADHD
and are given medication, it is important to know the safety and
efficacy of such treatment. The NIMH is sponsoring an ongoing
multi-site study, "Preschool ADHD Treatment Study" (PATS). It is the
first major effort to examine the safety and efficacy of a stimulant,
methylphenidate, for ADHD in this age group. The PATS study uses a
randomized, placebo-controlled, double-blind design. Children ages 3 to
5 who have severe and persistent symptoms of ADHD that impair their
functioning are eligible for this study. To avoid using medications at
such an early age, all children who enter the study are first treated
with behavioral therapy. Only children who do not show sufficient
improvement with behavior therapy are considered for the medication
part of the study. The study is being conducted at New York State
Psychiatric Institute, Duke University, Johns Hopkins University, New
York University, the University of California at Los Angeles, and the
University of California at Irvine. Enrollment in the study will total
165 children.
Which Treatment Should My Child Have?
For children with ADHD, no single treatment is the answer for every
child. A child may sometimes have undesirable side effects to a
medication that would make that particular treatment unacceptable. And
if a child with ADHD also has anxiety or depression, a treatment
combining medication and behavioral therapy might be best. Each child's
needs and personal history must be carefully considered.
Medications.
For decades, medications have been used to treat the symptoms of ADHD.
The medications that seem to be the most effective are a class of
drugs known as stimulants. Following is a list of the stimulants, their
trade (or brand) names, and their generic names. "Approved age" means
that the drug has been tested and found safe and effective in children
of that age.
| Trade Name |
Generic Name |
Approved Age |
| Adderall |
amphetamine |
3 and older |
| Concerta |
methylphenidate (long acting) |
6 and older |
| Cylert* |
pemoline |
6 and older |
| Dexedrine |
dextroamphetamine |
3 and older |
| Dextrostat |
dextroamphetamine |
3 and older |
| Focalin |
dexmethylphenidate |
6 and older |
| Metadate ER |
methylphenidate
(extended release) |
6 and older |
| Metadate CD |
methylphenidate
(extended release) |
6 and older |
| Ritalin |
methylphenidate |
6 and older |
| Ritalin SR |
methylphenidate
(extended release) |
6 and older |
| Ritalin LA |
methylphenidate
(long acting) |
6 and older |
| *Because of its potential for serious side effects
affecting the liver, Cylert should not ordinarily be considered as
first-line drug therapy for ADHD. |
The U.S. Food and Drug Adminstration (FDA) recently approved a
medication for ADHD that is not a stimulant. The medication,
Strattera®, or atomoxetine, works on the neurotransmitter
norepinephrine, whereas the stimulants primarily work on dopamine. Both
of theses neurotransmitters are believed to play a role in ADHD. More
studies will need to be done to contrast Strattera with the medications
already available, but the evidence to date indicates that over 70
percent of children with ADHD given Strattera manifest significant
improvement in their symptoms.
Some people get better results from one medication, some from
another. It is important to work with the prescribing physician to find
the right medication and the right dosage. For many people, the
stimulants dramatically reduce their hyperactivity and impulsivity and
improve their ability to focus, work, and learn. The medications may
also improve physical coordination, such as that needed in handwriting
and in sports.
The stimulant drugs, when used with medical supervision, are usually
considered quite safe. Stimulants do not make the child feel "high,"
although some children say they feel different or funny. Such changes
are usually very minor. Although some parents worry that their child
may become addicted to the medication, to date there is no convincing
evidence that stimulant medications, when used for treatment of ADHD,
cause drug abuse or dependence. A review of all long-term studies on
stimulant medication and substance abuse, conducted by researchers at
Massachusetts General Hospital and Harvard Medical School, found that
teenagers with ADHD who remained on their medication during the teen
years had a lower likelihood of substance use or abuse than did ADHD
adolescents who were not taking medications.13
The stimulant drugs come in long- and short-term forms. The newer
sustained-release stimulants can be taken before school and are
long-lasting so that the child does not need to go to the school nurse
every day for a pill. The doctor can discuss with the parents the
child's needs and decide which preparation to use and whether the child
needs to take the medicine during school hours only or in the evening
and on weekends too.
If the child does not show symptom improvement after taking a
medication for a week, the doctor may try adjusting the dosage. If
there is still no improvement, the child may be switched to another
medication. About one out of ten children is not helped by a stimulant
medication. Other types of medication may be used if stimulants don't
work or if the ADHD occurs with another disorder. Antidepressants and
other medications can help control accompanying depression or anxiety.
Sometimes the doctor may prescribe for a young child a medication
that has been approved by the FDA for use in adults or older children.
This use of the medication is called "off label." Many of the newer
medications that are proving helpful for child mental disorders are
prescribed off label because only a few of them have been
systematically studied for safety and efficacy in children. Medications
that have not undergone such testing are dispensed with the statement
that "safety and efficacy have not been established in pediatric
patients."
Side Effects of the Medications.
Most side effects of the stimulant medications are minor and are
usually related to the dosage of the medication being taken. Higher
doses produce more side effects. The most common side effects are
decreased appetite, insomnia, increased anxiety, and/or irritability.
Some children report mild stomach aches or headaches.
Appetite seems to fluctuate, usually being low during the middle of
the day and more normal by suppertime. Adequate amounts of food that is
nutritional should be available for the child, especially at peak
appetite times.
If the child has difficulty falling asleep, several options may be
tried—a lower dosage of the stimulant, giving the stimulant earlier in
the day, discontinuing the afternoon or evening dosage, or giving an
adjunct medication such as a low-dosage antidepressant or clonidine. A
few children develop tics during treatment. These can often be lessened
by changing the medication dosage. A very few children cannot tolerate
any stimulant, no matter how low the dosage. In such cases, the child
is often given an antidepressant instead of the stimulant.
When a child's schoolwork and behavior improve soon after starting
medication, the child, parents, and teachers tend to applaud the drug
for causing the sudden changes. Unfortunately, when people see such
immediate improvement, they often think medication is all that's
needed. But medications don't cure ADHD; they only control the symptoms
on the day they are taken. Although the medications help the child pay
better attention and complete school work, they can't increase
knowledge or improve academic skills. The medications help the child to
use those skills he or she already possesses.
Behavioral therapy, emotional counseling, and practical support will
help ADHD children cope with everyday problems and feel better about
themselves.
Facts to Remember About Medication for ADHD.
- Medications for ADHD help many children focus and be more
successful at school, home, and play. Avoiding negative experiences now
may actually help prevent addictions and other emotional problems later.
- About 80 percent of children who need medication for ADHD still need it as teenagers. Over 50 percent need medication as adults.
Medication for the Child with Both ADHD and Bipolar Disorder.
Since a child with bipolar disorder will probably be prescribed a
mood stabilizer such as lithium or Depakote®, the doctor will carefully
consider whether the child should take one of the medications usually
prescribed for ADHD. If a stimulant medication is prescribed, it may be
given in a lower dosage than usual.
|